How prescription-drug middlemen make their money

USA Today – The path of prescription drugs from the factory to the patient is complicated. Here, Julie Appleby of Kaiser Health News explains how money flows through the system and contributes to the cost of a 30-day supply of a hypothetical brand-name medicine. [continue reading]


Drugmakers Point Finger at Middlemen for Rising Drug Prices

Pharmacy-benefit managers and the rebates they command come in for criticism by pharmaceutical executives Wall Street Journal – As U.S. drug prices rise, drugmakers are playing down their role, instead heaping blame on the middlemen who help determine how medicines are priced. Some of the sharpest criticism has... [continue reading]


Letter: Support expanding health care to rural Iowa

The Cedar Rapids Gazette – By Brandon Gerleman As a third-year pharmacy student, I see the need for accessibility to quality health care services in Iowa. Many Iowans live in rural and underserved areas too far from quality health care. Roughly 44 percent of Iowans fall into... [continue reading]


PCAN asks CMS to delay Average Manufacturer Price rule implementation

Here is a link to the submission Dear Mr. Slavitt and Secretary Burwell, As the national board chairman of the Pharmacy Choice & Access Now (PCAN) coalition, I am writing to you to urge CMS to delay the effective date of CMS-2345-FC, the Medicaid Final Rule on... [continue reading]


Des Moines Register: Pharmacists can boost health care options in rural areas

Des Moines Register – By Andrew Wagner The Iowa Caucuses have come and gone, but Iowans’ engagement in the issues important to our state and our people remain. Just as we are fortunate to have the opportunity to meet and ask presidential candidates questions, our elected federal officials constantly... [continue reading]